Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: Therapeutic implications

Hepatology

Volumn 33, Issue 6, 2001, Pages 1488-1495

  Mehta, Anand ^a   Carrouée, Sandra ^b   Conyers, Bertha ^a   Jordan, Robert ^a   Butters, Terry ^b   Dwek, Raymond A ^b   Block, Timothy M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DNA POLYMERASE; GALACTOSE; GLUCOSIDASE; GLYCAN DERIVATIVE; IMINO ACID; N NONYL DEOXYNOJIRIMYCIN; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA REPLICATION; ENDOPLASMIC RETICULUM; GENOME; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS INHIBITION;

EID: 0034988078     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.25103     Document Type: Article

References (33)

1. Hepatitis B virus
2. Hepadnaviridae and their replication
3. The hepatitis B virus: The major etiology of hepatocellular carcinoma
4. Drug therapy: The treatment of chronic viral hepatitis
5. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′-dideoxy-3′-thiacytidine and related analogues
6. Mutations in the HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo
7. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin
8. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion
9. Aberrant trafficking and behavior of hepatitis B virus glycoproteins in cells in which glycosylation processing is inhibited
10. HBV envelope glycoproteins vary drastically in their sensitivity to glycan processing - Evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion
11. Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking
12. Association of folding intermediates of glycoproteins with calnexin during protein maturation
13. Role of N linked oligosaccharide recognition, glucose trimming and calnexin in glycoprotein folding and quality control
14. The molecular chaperone calnexin binds Glc1 Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins
15. Folding of VSV G protein: Sequential interaction with BIP and calnexin
16. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles
17. Formation of intracellular particles by hepatitis B virus large surface protein
18. Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships
19. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA
20. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles
21. Relationship between viral DNA synthesis and virion envelopment in hepatitis B virus
22. Nonselective utilization of the endomannosidase pathway for processing glycoproteins by human hepatoma (HepG2) cells
23. Characterization of endomannosidase inhibitors and evaluation of their effect on N-linked oligosaccharide processing during glycoprotein biosynthesis
24. Processing of viral envelope glycoprotein by the endomannosidase pathway: Evaluation of host cell specificity
25. Surface proteins of hepatitis B virus
26. Assembly of hepadnaviral virions and subviral particles
27. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir
28. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis agents
29. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation
30. Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis
31. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids
32. Intrahepatic induction of alpa/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice
33. Natural killer T cell activation inhibits hepatitis B virus replication in vivo